Chondroitin sulfate proteoglycans in the developing cerebral cortex: The distribution of neurocan distinguishes forming afferent and efferent axonal pathways
Abstract
The first thalamocortical axons to arrive in the developing cerebral cortex traverse a pathway that is separate from the adjacent intracortical pathway for early efferents, suggesting that different molecular signals guide their growth. We previously demonstrated that the intracortical pathway for thalamic axons is centered on the subplate (Bicknese et al. [1994] J. Neurosci. 14:3500‐3510), which is rich in chondroitin sulfate proteoglycans (CSPGs; Sheppard et al. [1991] J. Neurosci. 11:3928‐3942), whereas efferent axons cross the subplate to exit in a zone containing much less CSPG. To define the molecular composition of the subplate further, we used antibodies against CSPG core proteins and chondroitin sulfate disaccharides in an immunohistochemical analysis of their distribution in the developing neocortex of the rat. Immunolabeling for neurocan, a central nervous system‐specific CSPG (Rauch et al. [1992] J. Biol. Chem. 267:19537‐19547), and for chondroitin 6‐sulfate and unsulfated chondroitin becomes prominent in the subplate before the arrival of thalamic afferents. Immunolabeling is initially sparse in the cortical plate but appears later in maturing cortical layers. A postnatal decline in immunolabeling occurs uniformly for most proteoglycans, but, in the somatosensory cortex, labeling for neurocan, phosphacan, and chondroitin 4‐ and 6‐sulfate declines in the centers of the whisker barrels before the walls. In contrast to neurocan, immunolabeling for other proteoglycans is either uniformly distributed (syndecan‐1, N‐syndecan, 5F3, phosphacan, chondroitin 4‐sulfate), restricted to axons (PGM1), distributed exclusively on nonneuronal elements (2D6, NG2, and CD44), or undetectable (9. 2. 27, aggrecan, decorin). Thus, neurocan is a candidate molecule for delineating the intracortical pathway of thalamocortical axons and distinguishing it from that of cortical efferents.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Neurocan expression increased between E14 and postnatal day 3 and then decreased during early-late adolescence and into adulthood.
“Neurocan expression also increased between E14 and postnatal day (P) 3 and then decreased during early-late adolescence and into adulthood (Meyer-Puttlitz et al., 1996; Miller et al., 1996; Milev et al., 1998; Brückner et al., 2000).”
From The Perineuronal ‘Safety’ Net? Perineuronal Net Abnormalities in Neurological Disorders (2018) · cites this paper as Miller et al., 1996
The citation lists haven’t been fetched yet
References 97 · Cited by 114
- Authors
- Miller, B., Sheppard, A. M., Bicknese, A. R., & Pearlman, A. L.
- Affiliations
- Washington University in St. Louis (US)
- Corresponding author
- Pearlman, Alan L.
- Venue
- Journal of Comparative Neurology
- Publisher
- Wiley
- Published
- 1995-05-15
- Volume
- 355
- Issue
- 4
- Pages
- 615-628
- ISSN
- 0021-9967 (ISSN-L)
- 1096-9861
- OpenAlex
- W2039296171
- Cited by
- 114
- References
- 97
- Citations by year
- 2024: 4 · 2023: 2 · 2022: 1 · 2021: 1 · 2020: 3 · 2019: 1 · 2018: 2 · 2017: 1 · 2014: 1 · 2013: 1 · 2012: 3
- FWCI
- 4.17
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Comparative Neurology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5t32ns007027-18, 5r01ey000621-27)
- National Eye Institute (EY07057, EY00621)
- National Institute of Neurological Disorders and Stroke (NS07027)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Proteoglycans and glycosaminoglycans research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Axon Guidance and Neuronal Signaling
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Keywords
- chondroitin sulfate proteoglycans, neurocan, thalamocortical connections, subplate, cortical development, axon guidance, chondroitin-6-sulfate, chondroitin 4-sulfate, phosphacan, syndecan-1, somatosensory cortex
- MeSH terms
- Afferent Pathways, Animals, Antibodies, Monoclonal, Axons, Cerebral Cortex, Chondroitin Lyases, Chondroitin Sulfates, Efferent Pathways, Female, Glycosaminoglycans, Immunohistochemistry, Nerve Tissue Proteins, Pregnancy, Chondroitin Sulfate Proteoglycans, Thalamus, Vibrissae, Lectins, C-Type, Rats, Neurocan
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review